Cantel Medical Corp. (CMD): Price and Financial Metrics

Cantel Medical Corp. (CMD)

Today's Latest Price: $46.74 USD

1.07 (-2.24%)

Updated Oct 28 11:08am

Add CMD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

CMD Stock Summary

  • With a price/earnings ratio of 155.7, Cantel Medical Corp P/E ratio is greater than that of about 95.28% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of 380.83%, Cantel Medical Corp's debt growth rate surpasses 95.37% of about US stocks.
  • Cantel Medical Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -40.03%, greater than the shareholder yield of just 10.31% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cantel Medical Corp are EPC, NVT, CMCO, MTSC, and CSL.
  • CMD's SEC filings can be seen here. And to visit Cantel Medical Corp's official web site, go to

CMD Stock Price Chart Interactive Chart >

Price chart for CMD

CMD Price/Volume Stats

Current price $46.74 52-week high $79.50
Prev. close $47.81 52-week low $20.81
Day low $46.51 Volume 37,044
Day high $47.32 Avg. volume 590,472
50-day MA $48.21 Dividend yield N/A
200-day MA $46.88 Market Cap 1.97B

Cantel Medical Corp. (CMD) Company Bio

Cantel Medical Corporation provides infection prevention and control products and services in the healthcare market. The company operates in 5 segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Specialty Packaging. The company was founded in 1963 and is based in Little Falls, New Jersey.

CMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$46.74$30.56 -40%

We started the process of determining a valid price forecast for Cantel Medical Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cantel Medical Corp ranked in the 35th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 39.33%. In terms of the factors that were most noteworthy in this DCF analysis for CMD, they are:

  • Cantel Medical Corp's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 68.78% of tickers in our DCF set.
  • Cantel Medical Corp's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • Relative to other stocks in its sector (Healthcare), Cantel Medical Corp has a reliance on debt greater than 74.1% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CMD, try CRL, ENDP, GSK, EDAP, and HZNP.

CMD Latest News Stream

Event/Time News Detail
Loading, please wait...

CMD Latest Social Stream

Loading social stream, please wait...

View Full CMD Social Stream

Latest CMD News From Around the Web

Below are the latest news stories about Cantel Medical Corp that investors may wish to consider to help them evaluate CMD as an investment opportunity.

Cantel Hires Michael Drexel to SVP and Chief Technology Officer

LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer. Michael is based in Plymouth, Minnesota. Mr….

PR Newswire | October 1, 2020

Cantel Medical EPS beats by $0.25, beats on revenue

Cantel Medical (CMD): Q4 Non-GAAP EPS of $0.24 beats by $0.25; GAAP EPS of -$0.05 beats by $0.11.Revenue of $233.4M (-2.5% Y/Y) beats by $0.85M.Shares +4.9% PM.Press Release...

Seeking Alpha | September 17, 2020

Cantel Medical Corp. 2020 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Cantel Medical Corp. in conjunction with their 2020 Q4 earnings call....

SA Transcripts on Seeking Alpha | September 17, 2020

Earnings Scheduled For September 17, 2020

Companies Reporting Before The Bell • Apogee Enterprises (NASDAQ: APOG ) is projected to report quarterly earnings at $0.30 per share on revenue of $314.73 million. • Cantel Medical (NYSE: CMD ) is expected to report … Full story available on

Benzinga | September 17, 2020

Analysis on Impact of COVID-19- Global Suture Needles Market 2020-2024 | Evolving Opportunities with B. Braun Melsungen AG and Cantel Medical Corp. | Technavio

LONDON--(BUSINESS WIRE)-- #GlobalSutureNeedlesMarket--The Global Suture Needles Market will grow by $ 73.50 mn during 2020-2024

Business Wire | September 7, 2020

Read More 'CMD' Stories Here

CMD Price Returns

1-mo 3.73%
3-mo -4.81%
6-mo 40.95%
1-year -34.79%
3-year -52.07%
5-year -20.39%
YTD -33.96%
2019 -4.53%
2018 -27.51%
2017 30.87%
2016 26.97%
2015 43.94%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8116 seconds.